Related Experiment Video
Updated: Jul 19, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
A critique of Women's Health Initiative Studies (2002-2006)
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA. clarksciconsl@sbcglobal.net
Abstract:
The Women's Health Initiative Studies (WHI) were designed to examine the effects of estrogen and progestin (E+P; Prempro) and estrogen alone (Premarin) in post-menopausal women. The authors of the WHI studies and the National Heart Lung and Blood Institute (NHLBI) concluded that E+P treatment increased the risks of coronary heart disease, invasive breast cancer, stroke and venous thromboembolism. The following paper contains a reevaluation of these studies based on the graphic analysis of their tabulated data. In contrast to the conclusions reached by the WHI and the NHLBI, I conclude that treatment of post-menopausal women with estrogen and progestin (Prempro) does not increase the risks of cardiovascular disease, invasive breast cancer, stroke or venous thromboembolism. I also disagree with the claim that an increased risk of stroke existed in women treated with estrogen alone.
Related Concept Videos
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results from...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Bias in Epidemiological Studies
Dimensions of Health and Illness
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...